Article Details

Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv ...

Retrieved on: 2025-04-15 15:49:50

Tags for this article:

Click the tags to see associated articles and topics

Accord BioPharma, Inc. Announces Completion of UDENYCA® (pegfilgrastim-cbqv .... View article details on hiswai:

Excerpt

UDENYCA, a biosimilar to Neulasta® (pegfilgrastim), expands the company's portfolio of FDA-approved products and accelerates Accord BioPharma's growth ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo